| Value | ₹104.3 Cr |
|---|
BSE filing, NSE: GAUDIUMIVF. Summary written from the filing by ALFA Finder's alert engine.
Gaudium IVF And Women Health Ltd: key numbers
- Share price
- ₹106.75
- Market cap
- ₹777.0 Cr
- Revenue (annual)
- ₹104.4 Cr
- Net profit (annual)
- ₹24.46 Cr
- P/E (TTM)
- 33.6×Sector 47.0×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gaudium IVF And Women Health Ltd
All →Gaudium IVF And Women Health Board Meeting Date
GAUDIUM IVF AND WOMEN HEALTH LIMITED intimated a board meeting on 12 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. No financial figures are disclosed in this intimation.
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF conducted its 11th Annual General Meeting on September 28, 2026, via video conferencing, transacting all businesses specified in the AGM notice.
Gaudium IVF And Women Health Capacity Expansion
Gaudium IVF and Women Health Limited commenced operations at its new IVF Centre/Hub in Gurgaon, Haryana, effective September 24, 2026.
- new IVF center
- 1.0 centers
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Limited has intimated the exchange about sending physical letters to shareholders for accessing the Annual Report for FY 2025-26.
Gaudium IVF And Women Health Annual Report
Gaudium IVF and Women Health Limited submitted its Annual Report for the Financial Year 2025-26. The 11th Annual General Meeting is scheduled for September 28, 2026.
Other results update announcements
All →South West Pinnacle Exploration Results Update
South West Pinnacle Exploration reported H1 FY27 revenue of Rs.1194 Mn (up 16% YoY) and PAT of Rs.133 Mn (up 23%), with a record order book of INR 7,671 Mn. The release also highlights Jharkhand coal block progress and Oman JVs.
- Order book
- ₹767.1 Cr
Mukka Proteins Results Update
Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.
- Oman facility manufacturing capacity
- 37200.0 MTPA
Aztec Fluids & Machinery Results Update
Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.
Ramky Infrastructure Results Update
Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.
Striders Impex Results Update
Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.
Jaro Institute of Technology Management and Research Results Update
Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.